Bio-Techne (TECH) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $104.6 million.
- Bio-Techne's Cost of Revenue rose 141.06% to $104.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $422.8 million, marking a year-over-year increase of 283.44%. This contributed to the annual value of $429.4 million for FY2025, which is 1028.11% up from last year.
- Per Bio-Techne's latest filing, its Cost of Revenue stood at $104.6 million for Q4 2025, which was up 141.06% from $98.4 million recorded in Q3 2025.
- In the past 5 years, Bio-Techne's Cost of Revenue registered a high of $118.2 million during Q2 2025, and its lowest value of $75.3 million during Q1 2021.
- Over the past 5 years, Bio-Techne's median Cost of Revenue value was $94.0 million (recorded in 2023), while the average stood at $94.8 million.
- In the last 5 years, Bio-Techne's Cost of Revenue soared by 3289.19% in 2021 and then tumbled by 751.4% in 2025.
- Quarter analysis of 5 years shows Bio-Techne's Cost of Revenue stood at $85.6 million in 2021, then increased by 3.08% to $88.2 million in 2022, then rose by 8.83% to $96.0 million in 2023, then rose by 7.43% to $103.1 million in 2024, then grew by 1.41% to $104.6 million in 2025.
- Its Cost of Revenue was $104.6 million in Q4 2025, compared to $98.4 million in Q3 2025 and $118.2 million in Q2 2025.